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In 2015 in ICM and elsewhere studies are now addressing the evidence deficit in 
PICU: better outcome measures & consent processes should mean more, and better, 
RCTs. 
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 There is a staggeringly large gap between the number of patients admitted to 
the pediatric intensive care unit (PICU), and those enrolled into randomized 
controlled trials (RCTs) – the currency for acquiring new information for 
treatment in patient care. The “gap” is a ratio of 100-to-1, i.e., only one patient 
recruited to an RCT for every 100 patients admitted for PICU care.[1] This “focus 
on pediatrics” therefore explores how this gap might be closed.   
 
A plea for appropriate outcomes 
The recently published unadjusted mortality rate of 26.4 per 1,000 PICU 
admissions[2] in contemporary United States (US) PICU practice questions the 
legitimacy of mortality as an endpoint for RCTs. It is not relevant to the other 
973.6 per 1,000 admissions. Pollack et al.[2] addressed this problem by exploring 
three (or “trichotomous”) outcomes after PICU admission: significant new 
functional morbidity, intact survival and death.    
 Two articles in the Journal follow also question the confidence we might 
gain from mortality improvements alone. Aspesberro et al.[3] reviewed tools for 
measuring health-related quality of life (HRQL) after PICU admission and 
concluded that these instruments could be used to assess our 20-50% rates of 
morbidity, but the accompanying editorial[4] indicated that more work was 
needed before qualitative outcomes became the norm in our population. Second, 
van Zellem et al.[5] showed the expected worse performance in full-scale 
intelligence quotient (IQ), verbal IQ and visual memory in 47 survivors of cardiac 
arrest during childhood. Other, functional domains – executive functioning and 
visual-motor integration – were relatively intact, and there was often a 
difference between parent and teacher reports. Therefore, using summary 
variables for complex conditions, or resorting to parent questionnaire 
assessments in RCTs may introduce errors in outcomes assessment.  
 
Clinically usable information from observations 
Another focus in the Journal is large observational studies. Kanthimathinathan et 
al.[6] undertook a database review of 12,533 PICU admissions and reported 
unplanned endotracheal tube extubations at a rate of ~1 event per 2,000 
intubation days, per year.  
 Comparative effectiveness research (CER) is based on prospective 
observations that address the question of whether a complex package of care 
delivery works. The approach examines effectiveness in a homogeneous 
population (e.g., severe traumatic brain injury) where there is a known 
difference in outcome and a known difference in care delivery. That is, 
researchers can measure the difference in outcome and relate these to the 
package of care and its constituent components. The Approaches and Decisions 
for Acute Pediatric Traumatic Brain Injury (ADAPT) CER study is currently 
recruiting patients worldwide. This same approach may be important for 
complex conditions such as pediatric acute respiratory distress syndrome 
(pARDS).[7]  
 
Informative clinical experiments: RCTs in critical care 
In 2015 there were at least 12 RCTs reported in PICU patients (Table 1) 
(http://www.PICUtrials.net/). Two studies require further comment. The 
Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) 
study in 2,449 pediatric patients found that using a sedation protocol compared 
with usual care did not reduce the duration of mechanical ventilation.[8]  Of 
interest, though, 68% of cases developed “iatrogenic withdrawal”, which means 
that the future focus should be on this feature as an outcome measure.[9] In the 
Journal, Banupriya et al.[10] demonstrated the superiority of prophylactic 
probiotics in reducing the incidence of ventilator associated pneumonia (VAP 
from 39 to 22 per 1,000 ventilated days, p=0.02) in an environment with a very 
high baseline VAP rates. The natural question now is whether this benefit 
translates to PICUs where the pre-test rate of VAP is closer to 4 per 1,000 
ventilated days.  
 
New methodologies for enhancing patient recruitment to RCTs 
The recently published Impregnated central venous CATheters for prevention of 
bloodstream infection in CHildren (CATCH) trial compared standard with heparin 
or antibiotic coated central venous lines (CVL).[11] There was a small benefit of 
antibiotic coated CVLs with respect to blood stream infections. Of more interest, 
however, is the use of so-called “deferred consent” in the research report, which 
is worthy of further discussion. 
In the United Kingdom (UK) the term “deferred consent” is referred to as  
“research without prior consent”.   In US regulations, the term “waiver or 
alteration of informed consent” rather than the term “deferred consent” is used 
because the latter fails to describe the lack of opportunity to avoid or prevent a 
subject from receiving the intervention under investigation. To date, there have 
been a number of reports about this approach and we need to gain more insight 
from PICU families about the potential for this practice. For example, the CATCH 
trial was the first pediatric critical care RCT to use this approach since UK 
legislation changed in 2008. In the CONsent methods in childreN’s emergEncy 
medicine and urgent Care Trials (CONNECT) study a cohort of parents of children 
recruited into the CATCH study were interviewed.[12] The investigators found 
that parents supported research without prior consent and appreciated the 
reasons for using it as long as their child’s safety was not compromised. 
However, these parents would be concerned about not seeking prior consent in 
trials involving either “new” drug interventions or other potentially significant 
changes in clinical practice. Last, a report from a European group of pediatric 
clinical researchers described a new framework for informed consent processes 
under different time constraints,[13] which will be applicable to PICU studies. 
 
Moving the field forward and future RCTs  
There appear to the three areas that interest our authors in regard to future 
plans for RCTs. First, corticosteroids in pARDS may be one target,[7,14] but Yehya 
et al.[15] found that corticosteroid exposure for other indications was widespread 
in the PICU. However, recruitment to RCTs may be improved by using pulse 
oximetry to fractional inspired oxygen ratio as an index of severity.[16] Second, 
intravenous fluid resuscitation and responsiveness,[17,18] and there may soon be 
data from the Canadian SQUEEZE (septic shock reversal is quicker in pediatric 
patients randomized to an early goal directed fluid-sparing strategy versus usual 
care) and the UK FiSh (Fluids in Shock) studies.[19] Last, non-invasive 
ventilation,[20] and their may soon be data from the FIRST-line Support for 
Assistance in Breathing in Children (FIRST-ABC) feasibility study. 
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 Table 1. RCTs in Pediatric Intensive Care in 2015 by topic of care (see: 
http://epicc.mcmaster.ca and http://www.PICUtrials.net/) 
 
Topic Area Subject 
Respiratory  Protocolized sedation versus usual care during 
mechanical ventilation 
 Neurally adjusted ventilator assist 
 Inhaled nitric oxide 
 Post-endotracheal tube extubation care 
 Lung inflammation 
 Ventilator associated pneumonia  
 Bronchiolitis 
Cardiovascular  Sodium nitroprusside during prolonged infusion 
 Dopamine versus epinephrine in septic shock 
Hypothermia  Out-of-hospital cardiac arrest 
 Severe traumatic brain injury 
 
 
 
